z-logo
open-access-imgOpen Access
A rare case of COVID-19 pneumonia with severe hyperlipoproteinemia
Author(s) -
Masafumi Shimoda,
Yoshiaki Tanaka,
Kozo Morimoto,
Hiroyuki Kokutou,
Taro Abe,
Miyuri Suga,
Takashi Yoshiyama,
Kozo Yoshimori,
Ken Ohta
Publication year - 2022
Publication title -
oxford medical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.169
H-Index - 9
ISSN - 2053-8855
DOI - 10.1093/omcr/omac030
Subject(s) - medicine , covid-19 , pneumonia , betacoronavirus , virology , coronavirus infections , intensive care medicine , outbreak , infectious disease (medical specialty) , disease
A 55-year-old woman was admitted to our hospital for coronavirus disease 2019 (COVID-19) pneumonia. Her symptoms improved upon treatment with steroids, remdesivir and heparin. After discharge, she consumed excessive alcohol because of taste disorder due to COVID-19; she also had chylomicronemia with a triglyceride (TG) level of 8750 mg/dl. Chylomicrons and very-low-density lipoprotein were detected by electrophoresis, and she was diagnosed with severe hyperlipoproteinemia, suspected to be Type V hyperlipoproteinemia. She did not have any symptoms of pancreatitis, and her TG levels decreased with fat intake restriction and sobriety. This is a rare case of COVID-19 with hyperlipoproteinemia, and the causes of hyperlipoproteinemia might be associated with COVID-19 complications, steroids and/or lifestyle changes during the pandemic; therefore, changes in TGs should be observed carefully after the resolution of COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom